Teleflex Inc (TFX) Stock Price, Quote & News

Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 610-225-6800

Website: www.teleflex.com

Address:

550 East Swedesford Road, Suite 400, Wayne, United States

BillionerOfKing May. 11 at 5:23 PM

$TFX Current Stock Price: $131.09 Contracts to trade: $130.0 TFX May 15 2026 Call Entry: $2.05 Exit: $4.03 ROI: 97% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

StocktwitsEarnings May. 7 at 11:16 AM

$TFX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.18 down -108.65% YoY • Reported revenue of $548.26M down -21.75% YoY • Teleflex maintains its full year 2026 GAAP revenue growth guidance of 14.40% to 15.40% and adjusted diluted EPS guidance from $6.25 to $6.55, reflecting continued strategic execution.

0 · Reply

Estimize May. 5 at 12:25 PM

Wall St is expecting 1.22 EPS for $TFX Q1 [Reporting 05/07 BMO] http://www.estimize.com/intro/tfx?chart=historical&metric_name=eps&utm_cont

0 · Reply

1986iamwallstreet Apr. 22 at 12:26 PM

$TFX 👇🏿👇🏿👇🏿👇🏿 I told ya

1 · Reply

notreload_ai Apr. 22 at 10:02 AM

Private equity firms CVC Capital Partners and GTCR have submitted a joint offer to take medical device company $TFX private. Shares jumped on the news. https://notreload.xyz/xy/cvc-and-gtcr-team-up-to-take-medical-device-maker-teleflex-private/

0 · Reply

Kevin73ca Apr. 22 at 7:15 AM

$ASBP $GSUN $KYTX $TDTH $TFX

0 · Reply

PaulLaurent Apr. 22 at 6:00 AM

🚀📈 Top Gainers 📈🚀AH $KYTX $GSUN $TDTH $TFX $ASBP

0 · Reply

topstockalerts Apr. 22 at 1:13 AM

After Hours Top Gainers PT2 $GSUN $WETO $TFX $NEOV $ASBP

0 · Reply

OfficialStocktwitsUser Apr. 7 at 6:46 PM

$TFX RSI: 63.04, MACD: 1.4485 Vol: 4.56, MA20: 111.32, MA50: 110.55 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

1986iamwallstreet Apr. 2 at 3:06 PM

$TFX could sell the business for 8 to 10 billion

0 · Reply

Teleflex price target raised to $150 from $128 at Raymond James

2026-05-08T13:07:00.000Z - 5 days ago

Teleflex price target raised to $140 from $135 at Mizuho

2026-05-08T09:30:13.000Z - 5 days ago

Teleflex upgraded to Outperform from Sector Perform at RBC Capital

2026-05-07T15:53:21.000Z - 5 days ago

Teleflex reports Q1 adjusted EPS $1.39, consensus $1.22

2026-05-07T15:47:52.000Z - 5 days ago

Teleflex still sees 2026 adjusted EPS view $6.25-$6.55, consensus $6.72

May 7, 2026, 8:00 AM EDT - 6 days ago

Teleflex Earnings Call Transcript: Q1 2026

May 7, 2026, 6:30 AM EDT - 6 days ago

Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook

2026-04-30T12:53:24.000Z - 13 days ago

Teleflex names Jason Weidman as President and CEO

MDT

Apr 30, 2026, 6:30 AM EDT - 13 days ago

Teleflex Appoints Jason Weidman as President and CEO

Apr 23, 2026, 6:30 AM EDT - 20 days ago

Teleflex Announces First Quarter 2026 Earnings Conference Call Information

2026-04-22T13:13:38.000Z - 21 days ago

This Is Why Teleflex Stock (TFX) Rallied Today

Apr 21, 2026, 6:28 PM EDT - 21 days ago

CVC, GTCR weigh taking Teleflex private, Bloomberg News reports

2026-04-21T22:00:19.000Z - 21 days ago

CVC and GTCR considering Teleflex takeover, Bloomberg reports

Apr 17, 2026, 9:00 AM EDT - 26 days ago

Teleflex Incorporated Investigated by the Portnoy Law Firm

2026-04-14T11:48:24.000Z - 4 weeks ago

Teleflex price target raised to $135 from $125 at RBC Capital

2026-04-13T11:51:17.000Z - 4 weeks ago

Teleflex upgraded to Neutral from Underperform at BofA

Apr 10, 2026, 1:55 PM EDT - 4 weeks ago

Market Rebound Means Fewer Bargains. 14 Stocks With ‘Special Situations.

SON TDS TRS ZD ALKT ATKR BILL

Apr 9, 2026, 6:30 AM EDT - 4 weeks ago

Teleflex Announces Governance Updates

Mar 27, 2026, 2:31 PM EDT - 6 weeks ago

Irenic Comments on Teleflex's Announcement That It Is Open to Strategic Alternatives

2026-03-27T17:00:43.000Z - 6 weeks ago

Teleflex says ‘committed’ to acting in best interests of shareholders, company

2026-03-27T17:00:19.000Z - 6 weeks ago

Teleflex says Irenic ‘grossly mischaracterizes’ discussions between companies

Mar 27, 2026, 12:57 PM EDT - 6 weeks ago

Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution

2026-03-27T11:43:16.000Z - 6 weeks ago

Irenic sends letter to Teleflex board of directors

Mar 27, 2026, 7:30 AM EDT - 6 weeks ago

Irenic Sends Letter to Teleflex Board of Directors Regarding Its Refusal to Engage with Potential Acquirors

2026-03-27T09:16:22.000Z - 6 weeks ago

Teleflex upgraded to Outperform from Market Perform at Raymond James

Mar 12, 2026, 8:02 AM EDT - 2 months ago

o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning

2026-02-27T13:42:33.000Z - 2 months ago

Teleflex price target raised to $125 from $115 at RBC Capital

Feb 26, 2026, 8:00 AM EST - 2 months ago

Teleflex Earnings Call Transcript: Q4 2025

2026-02-26T12:02:57.000Z - 2 months ago

Teleflex sees 2026 adjusted EPS $6.25-$6.55 vs. $6.98 in 2025

2026-02-26T12:00:13.000Z - 2 months ago

Teleflex reports Q4 cont-op EPS (8c) vs. 77c last year

Feb 26, 2026, 6:45 AM EST - 2 months ago

Teleflex Announces Quarterly Dividend

Feb 26, 2026, 6:30 AM EST - 2 months ago

Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook

Feb 17, 2026, 6:30 AM EST - 3 months ago

Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information

2026-01-29T11:16:01.000Z - 3 months ago

Teleflex price target lowered to $116 from $139 at Wells Fargo

Jan 8, 2026, 6:30 AM EST - 4 months ago

Teleflex Announces Leadership Transition

Dec 9, 2025, 9:20 AM EST - 5 months ago

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Dec 9, 2025, 9:12 AM EST - 5 months ago

Teleflex to sell three of its businesses for $2.03 billion

Dec 9, 2025, 9:04 AM EST - 5 months ago

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Nov 18, 2025, 5:00 AM EST - 6 months ago

Teleflex Transcript: Jefferies London Healthcare Conference 2025

Nov 14, 2025, 8:00 AM EST - 6 months ago

Teleflex Transcript: Investor Update

Nov 14, 2025, 6:30 AM EST - 6 months ago

Teleflex to Present at the Jefferies Global Healthcare Conference in London

Nov 6, 2025, 8:00 AM EST - 6 months ago

Teleflex Earnings Call Transcript: Q3 2025

Nov 6, 2025, 6:30 AM EST - 6 months ago

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

Oct 16, 2025, 4:30 PM EDT - 7 months ago

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

Sep 11, 2025, 6:30 AM EDT - 8 months ago

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

Sep 9, 2025, 3:20 PM EDT - 8 months ago

Teleflex Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 6:30 AM EDT - 9 months ago

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 6:30 AM EDT - 9 months ago

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

Jul 31, 2025, 8:00 AM EDT - 10 months ago

Teleflex Earnings Call Transcript: Q2 2025

Jul 31, 2025, 6:30 AM EDT - 10 months ago

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

Jul 25, 2025, 11:15 AM EDT - 10 months ago

Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax

Jul 17, 2025, 6:30 AM EDT - 10 months ago

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

Jul 1, 2025, 6:30 AM EDT - 11 months ago

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

Jun 12, 2025, 6:30 AM EDT - 11 months ago

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

Jun 11, 2025, 6:30 AM EDT - 1 year ago

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

May 19, 2025, 6:30 AM EDT - 1 year ago

Teleflex Publishes 2024 Global Impact Report

May 15, 2025, 6:30 AM EDT - 1 year ago

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

May 14, 2025, 4:40 PM EDT - 1 year ago

Teleflex Transcript: Bank of America 2025 Healthcare Conference

May 13, 2025, 6:30 AM EDT - 1 year ago

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

BillionerOfKing May. 11 at 5:23 PM

0 · Reply

StocktwitsEarnings May. 7 at 11:16 AM

0 · Reply

Estimize May. 5 at 12:25 PM

Wall St is expecting 1.22 EPS for $TFX Q1 [Reporting 05/07 BMO] http://www.estimize.com/intro/tfx?chart=historical&metric_name=eps&utm_cont

0 · Reply

1986iamwallstreet Apr. 22 at 12:26 PM

$TFX 👇🏿👇🏿👇🏿👇🏿 I told ya

1 · Reply

notreload_ai Apr. 22 at 10:02 AM

0 · Reply

Kevin73ca Apr. 22 at 7:15 AM

$ASBP $GSUN $KYTX $TDTH $TFX

0 · Reply

PaulLaurent Apr. 22 at 6:00 AM

🚀📈 Top Gainers 📈🚀AH $KYTX $GSUN $TDTH $TFX $ASBP

0 · Reply

topstockalerts Apr. 22 at 1:13 AM

After Hours Top Gainers PT2 $GSUN $WETO $TFX $NEOV $ASBP

0 · Reply

OfficialStocktwitsUser Apr. 7 at 6:46 PM

0 · Reply

1986iamwallstreet Apr. 2 at 3:06 PM

$TFX could sell the business for 8 to 10 billion

0 · Reply

NorthStarStats Mar. 30 at 9:57 AM

Output from a custom NorthStarStats momentum scanner highlighting stocks with strengthening price structure and momentum. Setups to watch and study — not trade recommendations. $TFX Score 100, $ETR Score 70, $ADM Score 65, $KMI Score 50

0 · Reply

NewsAndFilings Mar. 11 at 7:16 PM

Medical Alert $BSX, $TFX, $ARAY, $CSDX, $NDRA Highlight Growing Hydrogel Tissue Spacer Market in Radiation Oncology https://thestreetreports.com/medical-alert-bsx-tfx-aray-csdx-ndra-highlight-growing-hydrogel-tissue-spacer-market-in-radiation-oncology/

0 · Reply

ZacksResearch Feb. 27 at 1:40 PM

$TFX misses big on Q4 earnings & revenue estimates. 📉 Despite 28.7% YoY GAAP revenue growth to $569M, GAAP EPS fell short of the Zacks Consensus Estimate by 48.3%, and GAAP revenue by 38.6%. Fundamental insights here 👉 https://www.zacks.com/stock/news/2876511/tfx-q4-earnings-revenues-miss-margins-down-stock-up-in-after-market?cid=sm-stocktwits-2-2876511-body-35446&ADID=SYND_STOCKTWITS_TWEET_2_2876511_BODY_35446

0 · Reply

ZacksResearch Feb. 27 at 12:40 PM

$TFX Q4 miss — yet the stock jumps? 📈 Earnings and revenues fell short, margins shrank, but after-hours gains came on 2026 growth guidance and a portfolio reshuffle. Find out what’s driving the rally 👉 https://www.zacks.com/stock/news/2876511/tfx-q4-earnings-revenues-miss-margins-down-stock-up-in-after-market?cid=sm-stocktwits-2-2876511-teaser-35445&ADID=SYND_STOCKTWITS_TWEET_2_2876511_TEASER_35445

0 · Reply

StocktwitsEarnings Feb. 26 at 12:09 PM

$TFX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$16.15 down -447.46% YoY • Reported revenue of $568.98M down -28.47% YoY • Teleflex expects 2026 GAAP revenue growth of 14.40% to 15.40% and adjusted diluted EPS from continuing operations of $6.25 to $6.55. The company anticipates pro forma adjusted constant currency revenue growth between 4.50% and 5.50%.

0 · Reply

SuperGreenToday Feb. 12 at 3:01 AM

$TFX Share Price: $106.95 Contract Selected: Jul 17, 2026 $105 Calls Buy Zone: $8.67 – $10.71 Target Zone: $14.69 – $17.95 Potential Upside: 60% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

DiamondCapital Feb. 11 at 5:16 PM

$CSDX one to look into asap tick tock. Their CS Protect-Hydrogel is currently under FDA review High value/low competition niche(hydrogel spacers) •SpaceOAR™ Hydrogel System acquired by $BSX Boston Scientific for $500M •Barrigel® acquired by Telefex $TFX for $600M And literally no other direct competitors in market This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of $500M-$600M. Not your typical OTC play. The potential is just massive on this one

0 · Reply

OfficialStocktwitsUser Feb. 3 at 1:13 AM

$TFX RSI: 38.17, MACD: -3.9248 Vol: 7.92, MA20: 108.04, MA50: 115.31 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DiamondCapital Feb. 2 at 3:06 PM

$CSDX Put this on your watchlist asap Their CS Protect-Hydrogel currently under FDA review Competitors: SpaceOAR™ Hydrogel System which was acquired by $BSX Boston Scientific for $500M Barrigel® acquired by Telefex $TFX for $600M And literally no other direct competitors in market Another similar one but not a (hydrogel spacer) is BioProtect Balloon Implant™ System currently in the process of being acquired for $200M as of Jan,26, 2026 This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of $500M-$600M Going to share more DD on this play..

1 · Reply

mielk92 Jan. 22 at 7:57 PM

$TFX Did they already start the buybacks?

0 · Reply

Valuation_Finance Jan. 21 at 2:35 PM

$TFX This stock is pretty widely followed. We had 3 value name investors buy in Q3 2025 and some insider buys last Summer at $115. That's why people are here, not because of anything exciting TFX does or makes. People figure there is a Superinvestor put here and we aren't too far away from the bottom.

1 · Reply

Market Cap	5.74B
Revenue (ttm)	1.99B
Net Income (ttm)	-905.64M
EPS (ttm)	N/A
PE Ratio	12.41
Forward PE	19.72
Profit Margin	-45.45%
Debt to Equity Ratio	0.85

Volume	771,100
Avg Vol	878,256
Day's Range	N/A - N/A
Shares Out	44.27M
Stochastic %K	59%
Beta	0.82
Analysts	Sell
Price Target	$143.75